ReviewCureus2026
Prognostic Significance of Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios for Complications of Diabetic Foot Ulcers: A Meta-Analysis.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the main consequences of diabetes mellitus is diabetic foot ulcers (DFUs), which often result in amputation and death. Two inflammatory biomarkers, platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR), measured in standard blood testing, have become potential indicators of many adverse outcomes in diabetes-related complications. However, evidence regarding their association with complications of DFUs remains limited and inconsistent. This study critically reviewed the prognostic value of both markers in predicting clinical consequences amongst patients with DFU. An inclusive literature search across PubMed, Web of Science, Embase, and ProQuest identified 22 relevant studies. Meta-analysis showed that NLR was associated with amputation (standardized mean difference (SMD) 0.78, p = 0.002) and osteomyelitis (SMD 0.31, p = 0.001). Similarly, PLR was associated with amputation (SMD 0.29, p = 0.005) and osteomyelitis (SMD 0.40, p < 0.001). Pooled diagnostic performance for mortality prediction showed good accuracy for NLR (area under the curve (AUC) 0.83) and moderate accuracy for PLR (AUC 0.75). Overall, both NLR and PLR are promising and readily available biomarkers for risk stratification in DFU patients. The results emphasize the necessity of standardized cut-off values and prospective validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.